Capitalmind
Capitalmind
Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial

1275 ArticlesStocks

30 / 128

Outlier in Focus: Suzlon: A New Wind Blows

We come across a large number of interesting stocks in Capitalmind SNAP Outliers, our discovery tool for stocks with momentum. Here’s a look at Suzlon, a ...
Suzlon.png

Outlier in Focus: That Sintex Demerger Makes It Worth A Dekho

We come across a large number of interesting stocks in Capitalmind SNAP Outliers, our discovery tool for stocks with momentum. Here’s a look at Sintex, a ...
Sintex.jpg

The Story: Why Reliance Was Fined Rs. 950 cr. for Trading RPL Shares

Reliance Industries was fined Rs. 950 cr. (around 447 cr. in retracted gains, and 500 cr. in interest) for a 2007 case of manipulation of Reliance Petroleum ...
What-did-Reliance-Do-with-RPL.png

Outlier in Focus – Sanofi India

We come across a large number of interesting stocks in Capitalmind SNAP Outliers, our discovery tool for stocks with momentum. Here’s a look at Sanofi ...
Sanofi_India_200_3223.jpg

Dr Reddy’s USFDA Inspection of Oncology Formulation Manufacturing Facility at Duvvada – Form 483 Revealed

Today we cover the Form 483 issued by the US FDA to Dr. Reddy’s oncology formulation manufacturing facility at Duvvada at Visakhapatnam, Andhra Pradesh. ...
Dr-Reddy-Duvvada-1.png

Vodafone-Idea Merge Into a Goliath To Take On Reliance Jio

Taking a leaf out of HDFC’s master plan of merging its insurance business with Max India to create the largest listed insurance company, Vodafone will now ...
Vodafone-Idea-Merger-6.png

Outlier in focus: Astral Poly Technik breaks out to an all time high

We come across a large number of interesting stocks in Capitalmind SNAP Outliers, our discovery tool for stocks with momentum. Here’s a look at Astral Poly ...
Astral-Product-Categories.png

Cadila Healthcare US FDA Inspection of Baddi – Form 483 Revealed

Today we cover the Form 483 issued by the US FDA to Cadila Healthcare’s formulations manufacturing plant at Baddi. On another note, the company is due ...
Cadila-483.png

IPO: DMart is a Wonderful Company, But With All This Excitement….

What’s to not like about the DMart IPO? This is a relatively small one (only 1870 cr.) with a price of around Rs. 299. That’s about 6.25 cr. shares ...
Dmart.png

Dr Reddy’s Laboratories US FDA Inspection of Miryalaguda – Form 483 Revealed

Today we cover the Form 483 issued by the US FDA to Dr. Reddy’s API manufacturing plant at Miryalaguda. On another note, the company’s formulation ...
Dr-Reddy-Miryalguda-2.png